Subscribe To Data Package
$358 / YEAR
This data package contains information on labelers and products in the Medicaid Drug Utilization Review Program as collected through the Newly Revised Medicaid Drug Utilization Review Annual Report Survey released in 2014, regarding prescriptions and reimbursements.
The Medicaid Drug Utilization Review (DUR) Program promotes patient safety through state-administered utilization management tools and systems that interface with CMS’ Medicaid Management Information Systems (MMIS).
1. CMS Drug Utilization Review ($179)
2. CMS Opioid Utilization Review ($179)